GIC-102

· GI Cell, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GIC-102, covering 2024-07-09 to 2024-07-09. Get the full timeline:

Most recent: Clinical Trial Update: GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies [Phase 1, Phase 2]

See pricing